Browsing Tag:Agencys

three-f-d-a-advisers-resign-over-agencys-approval-of-alzheimers-drug
In a marked disagreement over the Food and Drug Administration's approval of Biogen's controversial Alzheimer's drug earlier this week, three scientists stepped down from the independent committee that advised the agency on the treatment."This could be the worst regulatory decision the FDA has made that I can remember," said Dr. Aaron Kesselheim, professor of medicine at Harvard Medical...
Continue reading
0 Comments
Share